Article

wsj.com on 2016-08-24 15:21

Mallinckrodt to Sell Nuclear-Imaging Operations

Mallinckrodt PLC agreed to sell its nuclear-imaging operations to IBA Molecular in a deal that includes a pretax upfront payment of roughly $574 million.

Related news

Mallinckrodt to sell nuclear imaging business for $690 million bizjournals.com
MMallinckrodt sells nuclear imaging business for $690 million marketwatch.com
Mallinckrodt to sell Canadian drug manufacturing unit for $250M bizjournals.com
Canada
Mallinckrodt to sell hemostasis products in $185 million deal bizjournals.com
Mallinckrodt open to sale of nuclear imaging, but not ‘anytime soon’bizjournals.com
Mallinckrodt seeks buyer for nuclear unit: Report bizjournals.com
McCaskill expands opioid probe to include Mallinckrodt bizjournals.com
Mallinckrodt to Buy Critical Care Company wsj.com
Entergy in Talks to Sell FitzPatrick Nuclear Plant wsj.com
TGlobal Radiopharmaceutical Market Report 2022 by Size and Share, Trends, Key Regions, Leading Companies – Bracco Imaging, Bayer, Mallinckrodt, Nordion thetechtalk.org
Pacific Ocean , Asia
Drugmaker Mallinckrodt settles case on kickbacks to doctors reviewtimes.com
Philadelphia
Mallinckrodt added to Missouri attorney general's probe of opioid manufacturers bizjournals.com
Missouri
Mallinckrodt subsidiaries to raise $750 million for acquisition bizjournals.com
BMallinckrodt Soars After the Company Agrees to Opioid Settlement barrons.com
Stock Island , Wall Street , The Settlement
MMallinckrodt to sell BioVectra business for $250 million, stock surges marketwatch.com
Mallinckrodt to pay $100 million in settlement with FTC bizjournals.com
Mallinckrodt to settle two opioid suits for $24M bizjournals.com
Sucampo's proposed sale to Mallinckrodt would yield blockbuster payouts bizjournals.com
Mallinckrodt agrees to buy Maryland drug maker for $1.2 billion bizjournals.com
Maryland